Quantitative and automatic plan-of-the-day assessment to facilitate adaptive radiotherapy in cervical cancer

医学 宫颈癌 直肠 核医学 放射治疗 分割 骨盆 四分位间距 癌症 放射科 计算机科学 人工智能 外科 内科学
作者
Sarah A. Mason,Lei Wang,S. Alexander,Susan Lalondrelle,H. McNair,Emma Harris
出处
期刊:Physics in Medicine and Biology [IOP Publishing]
卷期号:70 (12): 125020-125020
标识
DOI:10.1088/1361-6560/ade197
摘要

Abstract Objective. To facilitate implementation of plan-of-the-day (POTD) selection for treating locally advanced cervical cancer (LACC), we developed a POTD assessment tool for CBCT-guided radiotherapy (RT). A female pelvis segmentation model (U-Seg3) is combined with a novel quantitative standard operating procedure (qSOP) to identify optimal and acceptable plans. Approach. The planning CT[i], corresponding structure set[ii], and manually contoured CBCTs[iii] ( n = 226) from 39 LACC patients treated with POTD ( n = 11) or non-adaptive RT ( n = 28) were used to develop U-Seg3, an algorithm incorporating deep-learning and deformable image registration techniques to segment the low-risk clinical target volume (LR-CTV), high-risk CTV (HR-CTV), bladder, rectum, and bowel bag. A single-channel input model (iii only, U-Seg1) was also developed. Contoured CBCTs from the POTD patients were (a) reserved for U-Seg3 validation/testing, (b) audited to determine optimal and acceptable plans, and (c) used to empirically derive a qSOP that maximised classification accuracy. Main results. The median (interquartile range) dice similarity coefficient (DSC) between manual and U-Seg3 contours was 0.83 [0.80], 0.78 [0.13], 0.94 [0.05], 0.86 [0.09], and 0.90 [0.05] for the LR-CTV, HR-CTV, bladder, rectum, and bowel. These were significantly higher than U-Seg1 in all structures but bladder. The qSOP classified plans as acceptable if they met target coverage thresholds (LR-CTV 99%, HR-CTV 99.8%), with lower LR-CTV coverage ( 95%) sometimes allowed. The acceptable plan minimizing bowel irradiation was considered optimal unless substantial bladder sparing could be achieved. With U-Seg3 embedded in the qSOP, optimal and acceptable plans were identified in 46/60 and 57/60 cases. Significance. U-Seg3 outperforms U-Seg1 and all known CBCT-based segmentation models of the female pelvis both in terms of scope and accuracy (median DSC improvement ranging from 0.03–0.06). The tool combining U-Seg3 and the qSOP identifies optimal plans with equivalent accuracy as two observers. In an implementation strategy whereby this tool serves as the second observer, plan selection confidence and decision-making time could be improved whilst simultaneously reducing the required number of POTD-trained radiographers by 50%.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
辛勤的乌完成签到,获得积分10
1秒前
SciGPT应助xuwen采纳,获得10
1秒前
3秒前
labi完成签到 ,获得积分10
3秒前
3秒前
tiptip应助寂寞的听双采纳,获得10
4秒前
英俊的铭应助fifi采纳,获得10
5秒前
外向青文完成签到,获得积分20
5秒前
找找完成签到 ,获得积分10
5秒前
5秒前
CodeCraft应助耶啵耶啵采纳,获得10
5秒前
孟yifan发布了新的文献求助10
6秒前
6秒前
7秒前
skq发布了新的文献求助10
7秒前
superhanlei完成签到 ,获得积分10
9秒前
10秒前
11秒前
12秒前
学术山芋完成签到,获得积分10
12秒前
找找找完成签到 ,获得积分10
13秒前
cc完成签到,获得积分10
13秒前
kyhoy完成签到 ,获得积分20
14秒前
lkylucky发布了新的文献求助10
14秒前
张益龙完成签到,获得积分20
15秒前
15秒前
17秒前
学术山芋发布了新的文献求助10
18秒前
UY完成签到,获得积分10
19秒前
zhenanCheng发布了新的文献求助10
20秒前
医然为你发布了新的文献求助10
22秒前
爱吃食物的女孩完成签到 ,获得积分10
22秒前
典雅的面包完成签到,获得积分10
22秒前
Prof.Z发布了新的文献求助100
22秒前
23秒前
Prof.Z发布了新的文献求助100
23秒前
Prof.Z发布了新的文献求助100
24秒前
所所应助csj采纳,获得30
25秒前
带你去月球完成签到,获得积分10
25秒前
lkylucky完成签到,获得积分10
27秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Applied Min-Max Approach to Missile Guidance and Control 5000
Metallurgy at high pressures and high temperatures 2000
Inorganic Chemistry Eighth Edition 1200
The Organic Chemistry of Biological Pathways Second Edition 1000
The Psychological Quest for Meaning 800
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6327265
求助须知:如何正确求助?哪些是违规求助? 8143826
关于积分的说明 17077176
捐赠科研通 5380942
什么是DOI,文献DOI怎么找? 2854558
邀请新用户注册赠送积分活动 1832179
关于科研通互助平台的介绍 1683377